Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer – Proceedings from breast cancer expert group meeting

ConclusionThe current article will serve as a comprehensive guide for optimizing the management of HR  + HER2 − mBC. The proposed breast cancer registry will help identify unmet needs and develop strategic regional policies to help improve access to optimized care for HR + HER2 − mBC.
Source: BMC Proceedings - Category: Biomedical Science Source Type: research